Linking a Type 2 Drug to Too Much Acid in the Blood

 Linking a Type 2 Drug to Too Much Acid in the Blood

by | Jun 8, 2015 | Weight Management

The FDA recently announced that sodium-glucose cotransporter-2 (SGLT2) inhibitors such as canaglifozin (Invokana), dapaglifozin (Farxiga), dapagliflozin and metformin (Xigduo XR), empagliflozin (Jardiance),  and empagliflozin and linagliptin combination (Glyxambi) may be linked to cases of increased levels of acid in the blood. SGLT2 inhibitors is the...

Are Vitamins Part of the Fountain of Youth?

 Are Vitamins Part of the Fountain of Youth?

by | Jun 3, 2015 | Health

Obviously, you know what vitamins are, but what are telomeres? The telomeres are sections of DNA at the end of each chromosome, that serve as a cap to the genetic material and function to ensure the cell’s chromosomes do not fuse with each other or rearrange during normal cell replication, which could lead to cancer.The aging and lifespan of normal,...

Is a Cheaper, Off-Label Drug Better for Diabetic Eye Disease?

 Is a Cheaper, Off-Label Drug Better for Diabetic Eye Disease?

by | May 21, 2015 | Medicine Cabinet

Genentech is a biotech company based in South San Francisco, Ca., and is a member of the Roche Group. The company has the distinction of having two medicines being used for the treatment of diabetic retinopathy. One of these drugs, Lucentis (ranibizumab), was approved back in February to be used in the treatment of diabetes retinopathy for patients with...

GLP-1 Agonist Use in Type 1 Diabetes

 GLP-1 Agonist Use in Type 1 Diabetes

by | May 8, 2015 | Medicine Cabinet

For those who have type 1 diabetes as well as those who help treat it, it goes without saying that managing type 1 diabetes is very complex and can be frustrating. However, every enterprising type 1 that I work with will look at every treatment angle possible to help reduce blood glucose, hypoglycemia, and weight gain. The term “off-label” does not scare...

Preventing the Onset of Type 2 Diabetes

 Preventing the Onset of Type 2 Diabetes

by | May 1, 2015 | Practice Management

The U.S. diabetes statistics are well known: 29.1 million people, or 9.3% of the American population has diabetes and 8.1 million are undiagnosed. The statistics for prediabetes are perhaps less well known but more significant for the future of American health and healthcare. 86 million Americans, or 1 in 3, have prediabetes but nearly 90 percent of these...